News

The suspension of this program follows the firing and departure of up to 20,000 HHS employees, including key personnel such ...
The head of the Food and Drug Administration has repeatedly claimed in recent interviews that no scientists have been laid ...
The severance of key employees seemingly affects administrative and scientific roles vital to food safety operations.
Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...
Food and drink companies will have to stop using petroleum-based dyes by the end of 2026, Health and Human Services officials ...
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the impact of mass layoffs at the FDA, impact on ...
The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...
President Donald Trump has signed an executive order looking to modify the Inflation Reduction Act’s (IRA's) drug price ...
The price of pharmaceuticals will likely go up soon, and generics are poised to be hit the hardest.
Proposed tariffs on pharmaceutical imports could destabilize U.S. generic drug supply, warns Dr. Scott Gottlieb.
Dr. Scott Gottlieb, former FDA Commissioner, joins 'Squawk Box' to discuss current pharmaceutical imports under investigation, moving production for branded and generic drugs elsewhere, and much more.
I called RFK Jr. an "extinction-level" threat to US biomedical science and public health. That extinction is under way.